Clinical Trial Update: Cisplatin or ImmunoTHerapy in Association With Definitive Radiotherapy in HPV-related oropharyngEal Squamous Cell Carcinoma: a Randomized Phase II Trial. [Phase 2]

View source ↗

Summary

A randomized Phase II trial comparing cisplatin-based radiotherapy to immunotherapy-based radiotherapy for HPV-related oropharyngeal squamous cell carcinoma has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Immunotherapy (unspecified agent)

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Oropharyngeal Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED